CONFIDENTIAL Dr. Rajesh C. Shrotriya M.D. Chief Executive Officer Spectrum Pharmaceuticals, Inc. 157 Technology Drive Irvine, CA 92618 Dear Dr. Shrotriya:Placement Agent Agreement • June 18th, 2009 • Spectrum Pharmaceuticals Inc • Pharmaceutical preparations • New York
This letter (the “Agreement”) constitutes the agreement between Rodman & Renshaw, LLC (“Rodman” or the “Placement Agent”) and Spectrum Pharmaceuticals, Inc. (the “Company”), that Rodman shall serve as the exclusive placement agent for the Company, on a “reasonable best efforts” basis, in connection with the proposed placement, to close on or prior to June 18, 2009 (the “Placement”), of registered securities of the Company, consisting of shares (the “Shares”) of the Company’s common stock, par value $.001 per share (the “Common Stock”), and warrants to purchase shares of Common Stock (the “Warrants” and together with the Shares, the “Securities”). The terms of such Placement and the Securities shall be mutually agreed upon by the Company and the purchasers (each, a “Purchaser” and collectively, the “Purchasers”) and nothing herein constitutes that Rodman would have the power or authority to bind the Company or any Purchaser or an obligation for the Company to issue any Securities or com
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 18th, 2009 • Spectrum Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of June 15, 2009, between Spectrum Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
